- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced Malignant Neoplasm in Hong Kong
Total 172 results
-
The University of Hong KongCompletedMalignant Childhood NeoplasmChina
-
Organisation for Oncology and Translational ResearchUnknownHormone Receptor Positive Malignant Neoplasm of BreastChina
-
New Beta Innovation LimitedTerminated
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong... and other collaboratorsUnknownMalignant Pleural EffusionHong Kong
-
The University of Hong KongQueen Mary Hospital, Hong KongCompletedAdvanced Cancer | AcupressureHong Kong
-
Chinese University of Hong KongRecruitingPericardial Effusion MalignantHong Kong
-
Chinese University of Hong KongTerminatedPancreatic Cancer | Hepatic Malignant TumorsHong Kong
-
The University of Hong KongRecruitingPleural Effusion, Malignant | Lung Cancer Stage IV | Chest TubesHong Kong
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
The University of Hong KongCompletedLung Cancer | Pleural Effusion, MalignantHong Kong
-
Hong Kong Children's HospitalThe University of Hong KongRecruitingCarcinoma | Cancer | Solid Tumor | MalignancyHong Kong
-
New Epsilon Innovation LimitedActive, not recruitingAdvanced Solid Tumor | Relapsed AML | Refractory AMLHong Kong
-
Aegera TherapeuticsChinese University of Hong KongCompletedAdvanced Hepatocellular CarcinomaChina
-
Chinese University of Hong KongCompletedAdvanced Nasopharyngeal CarcinomaHong Kong
-
The University of Hong KongQueen Mary Hospital, Hong KongRecruitingTai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer PatientsAdvanced Lung Non-Small Cell CarcinomaHong Kong
-
Lee's Pharmaceutical LimitedRecruitingAdvanced Hepatocellular CarcinomaChina
-
The University of Hong KongNot yet recruitingPain Management | MalignancyHong Kong
-
The University of Hong KongRecruitingCancer | Graft Vs Host Disease | Haematological MalignancyHong Kong
-
The University of Hong KongResearch Grants Council, Hong KongRecruitingFear of Cancer Progression | Metacognition-based Intervention | Supportive-expressive Based Intervention | Psychooncology | Advanced or Metastatic CancerHong Kong
-
Zai Lab (Shanghai) Co., Ltd.TerminatedAdvanced Hepatocellular Carcinoma (HCC)China
-
The University of Hong KongUnknownAdvanced Hepatocellular Carcinoma | Metastatic Hepatocellular CarcinomaChina
-
Chinese University of Hong KongRecruitingColorectal Adenoma | Colorectal Polyp | Advanced AdenomaHong Kong
-
Chinese University of Hong KongRoche DiagnosticsRecruitingHeart Failure | Infections | Renal Failure | Cirrhosis | Fluid Overload | Pleural Effusion | Malignant Neoplasm | HypoalbuminemiaHong Kong
-
Chinese University of Hong KongTerminatedIntractable Abdominal Pain Secondary to Inoperable MalignancyChina
-
AstraZenecaCompletedCancer | Advanced Hepatocellular CarcinomaKorea, Republic of, Hong Kong
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
Shenzhen People's HospitalSixth Affiliated Hospital, Sun Yat-sen University; The University of Hong Kong-Shenzhen...RecruitingLocally Advanced Rectal CarcinomaChina
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Novartis PharmaceuticalsTerminatedAdvanced Hepatocellular Carcinoma With c-MET DysregulationChina, Hong Kong, Thailand, Singapore
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Harbour BioMed US, Inc.CompletedAdvanced Solid TumorAustralia, China, Hong Kong
-
Novartis PharmaceuticalsWithdrawnAdvanced Hepatocellular CarcinomaGermany, Australia, Hong Kong, Switzerland, Spain, France, United States
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingLocally Advanced Nasopharyngeal CarcinomaChina
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Malignant Solid TumorsUnited States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocally Advanced or Metastatic and Unresectable HCCUnited States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
-
Treadwell Therapeutics, IncTIO Discovery EngineRecruitingAdvanced Solid MalignanciesUnited States, Hong Kong, Canada
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Boston PharmaceuticalsCompletedAdvanced Nonhaematologic MalignanciesUnited States, Korea, Republic of, Taiwan, France, Hong Kong, Belgium, Spain
-
Novartis PharmaceuticalsCompletedAdvanced Hepatocellular CarcinomaTaiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
-
Aadi Bioscience, Inc.RecruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmKorea, Republic of, United States, Puerto Rico
-
Turning Point Therapeutics, Inc.Zai Lab (Shanghai) Co., Ltd.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, China, Japan, Australia, Belgium, Canada, Denmark, France, Germany, Hong Kong, Hungary, Italy, Korea, Democratic People's Republic of, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Taiwan, United Kingdom
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico